CorWave Appoints New CTO and VP to Enhance Leadership Team
CorWave has appointed Andreas Fleischli as Chief Technology Officer and Daniel Lexcen as Vice President Clinical & Scientific Affairs. These appointments are critical as CorWave advances its clinical program and prepares for industrial scaling of its cardiac assist technology.
Theia Market Signal Identification - AI Assisted
CorWave has made two significant appointments: Andreas Fleischli as Chief Technology Officer and Daniel Lexcen as Vice President Clinical & Scientific Affairs. These roles aim to bolster CorWave's leadership as the company progresses with its clinical investigation and scaling efforts for its undulating membrane heart pump.
The strategic hires are crucial for enhancing operational capabilities and supporting future growth in the cardiac assist device market. The company's ongoing clinical trials highlight the importance of leadership in navigating complex medical device regulations and market demands.
Comments